Susquehanna International Group
KPRX icon

Susquehanna International Group’s Kiora Pharmaceuticals KPRX Stock Holding History

Susquehanna International Group’s Portfolio KPRX Stock Details KPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-11,382
Closed -$41.7K – 12746
2024
Q3 		$41.7K Buy
+11,382
New +$44.4K ﹤0.01% 11448
2022
Q2 		– Sell
-31
Closed -$7K – 13452
2022
Q1 		$7K Buy
+31
New +$8.11K ﹤0.01% 12787
2019
Q3 		– Sell
-41
Closed -$53K – 10530
2019
Q2 		$53K Buy
+41
New +$60.5K ﹤0.01% 9830
2018
Q4 		– Sell
-13
Closed -$22K – 9488
2018
Q3 		$22K Buy
+13
New +$34.9K ﹤0.01% 8985
2016
Q2 		– Sell
-2
Closed -$35K – 8963
2016
Q1 		$35K Buy
+2
New +$30.9K ﹤0.01% 8729

Other funds holding KPRX

ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $249M AUM 80.12% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
VCIM
Velan Capital Investment Management Alpharetta, Georgia $160M AUM 517.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
NA
NewEdge Advisors New Orleans, Louisiana $27.7B AUM 22.98% 1-Year Est. Return

Susquehanna International Group's KPRX Position: Q4 2024 in Review

Susquehanna International Group sold out of Kiora Pharmaceuticals (KPRX) in Q4 2024, closing a stake of 11,382 shares — an estimated $41.7K sold.

Susquehanna International Group first reported a position in KPRX in Q1 2016 and held it in 5 quarters. The position peaked at $53K in Q2 2019. 16 funds tracked by Wall St. Rank hold KPRX as of Q4 2024.

  • Susquehanna International Group reported no remaining Kiora Pharmaceuticals position as of Q4 2024 after selling out during the quarter.
  • Susquehanna International Group sold 11,382 Kiora Pharmaceuticals shares in Q4 2024, an estimated $41.7K.
  • Susquehanna International Group first reported a position in Kiora Pharmaceuticals in Q1 2016 and held it in 5 quarters.
  • Susquehanna International Group's Kiora Pharmaceuticals position peaked at $53K in Q2 2019.
  • 16 funds tracked by Wall St. Rank held Kiora Pharmaceuticals as of Q4 2024.

Based on Susquehanna International Group's 13F filing for Q4 2024, filed 14 Feb 2025.